Why the study?
Does the metabolic syndrome amplify target organ damage in hypertensive patients regardless of age?
Does the metabolic syndrome amplify target organ damage in hypertensive patients regardless of age?
Metabolic syndrome synergistically accelerates target organ damage in both young and elderly hypertensive patients, highlighting the need for comprehensive risk factor management.
Supports comprehensive risk assessment across ages in hypertensive patients with metabolic syndrome; hypothesis-generating for integrated management trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cuspidi et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: